Skip to main content

Table 1 Demographic, clinical, anatomopathological characteristics and PCR data from patients with high-risk prostate cancer (needle biopsies) and normal prostate controls (cytoprostatectomies)

From: The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness

Parameter Overall NP PCa
Age, Median (IQR) 76 (68.2–81.7) 70 (61.5–81) 78 (69–81.7)
PSA level, ng/ml, median (IQR)    54.5 (37.2–212)
BMI, median (IQR) 27.6 (25.4–30.3) 25.8 (24.4–32.5) 27.9 (25.5–30.1)
Gleason score
 = 7 - - 18/52 (35%)
 > 7 - - 34/52 (65%)
Extraprostatic extension - - 18/52 (35%)
Perineural infiltration - - 27/52 (52%)
% of samples where mRNA expression was detected:
 Ghrelin 56/64 (87,5%) 9/12 (83,3%) 47/52 (90%)
 In1-ghrelin 54/64 (84,5%) 8/12 (66,6%) 46/52 (88,5%)
 GHSR-1a 1/27 (3,7%) 0/7 (0%) 1/20 (5%)
 GHSR-1b 7/28 (25,5%) 2/8 (25%) 5/20 (20%)
  1. NP Normal prostate, PCa prostate cancer, No number, EE extraprostatic extensión, PI perineural infiltration